Referred to the House Committee on Energy and Commerce.
The Humane Cosmetics Act of 2025 would ban most cosmetic animal testing conducted or contracted in the United States, and prohibit sale or interstate transport of cosmetics developed using such testing, starting one year after enactment. It bars reliance on animal-test safety data generated after that date except under narrow exemptions, creates civil penalties up to $10,000 per violation, requires manufacturers to provide certain records on request, and preempts state rules that differ from the Act.
Progressives emphasize animal welfare and alternative methods
Targeted reform with sympathetic constituency groups and compromise exemptions increases House prospects, though some industry opposition likely.
The Humane Cosmetics Act of 2025 would ban most cosmetic animal testing conducted or contracted in the United States, and prohibit sale or interstate transport of cosmetics developed using such testing, starting one year after enactment.
It bars reliance on animal-test safety data generated after that date except under narrow exemptions, creates civil penalties up to $10,000 per violation, requires manufacturers to provide certain records on request, and preempts state rules that differ from the Act.
Exemptions include testing done to satisfy foreign regulators, Secretary‑authorized testing after a public process, products regulated as drugs, and non‑cosmetic regulatory requirements.
Substantive but narrow policy with built‑in exemptions; could pass lower chamber with bipartisan support, but Senate obstacles and stakeholder resistance reduce odds.
How solid the drafting looks.
Progressives emphasize animal welfare and alternative methods
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize animal welfare and alternative methods
This persona would generally welcome the bill as a strong federal step to end animal testing for cosmetics and accelerate non‑animal safety methods.
They would see it as aligning federal policy with animal welfare, ethical consumer demand, and scientific alternatives, while watching exemptions closely.
This persona would view the bill as a reasonable move toward ending cosmetic animal testing but would be cautious about implementation and safety tradeoffs.
They would seek clearer guidance, transitional support for industry, and robust validation of alternatives before full enforcement.
This persona would be skeptical, seeing the bill as federal regulatory expansion that creates new compliance costs and potential trade frictions.
They may also view civil penalties and data‑use restrictions as burdensome to businesses and scientific flexibility.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Substantive but narrow policy with built‑in exemptions; could pass lower chamber with bipartisan support, but Senate obstacles and stakeholder resistance reduce odds.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize animal welfare and alternative methods
Substantive but narrow policy with built‑in exemptions; could pass lower chamber with bipartisan support, but Senate obstacles and stakehol…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Humane Cosmetics Act of 2025.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.